These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22760097)

  • 1. Very early MS--insights from MRI.
    Simon J
    Mult Scler; 2012 Oct; 18(10):1372-6. PubMed ID: 22760097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of MRI in the diagnosis of multiple sclerosis.
    Traboulsee AL; Li DK
    Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H; Geurts JJ
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
    Dale RC; Pillai SC
    Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M; Agosta F
    Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gray matter involvement in patients with multiple sclerosis as shown by magnetic resonance imaging.
    Rumzan R; Chen X; Li YM
    Chin Med J (Engl); 2012 Jul; 125(13):2361-4. PubMed ID: 22882862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature].
    Sierra-Marcos A; Mitjana R; Castilló J; Edo MC; Horga-Hernández A; Tintoré M; Río-Izquierdo J; Auger-Acosta C; Rovira A; Montalban X
    Rev Neurol; 2010 Aug; 51(3):129-34. PubMed ID: 20645263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI outcomes in the diagnosis and disease course of multiple sclerosis.
    Simon JH
    Handb Clin Neurol; 2014; 122():405-25. PubMed ID: 24507528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A calculation method for semi automatic follow up of multiple sclerosis by magnetic resonance eco planar perfusion imaging.
    Placidi G; Sabatini M; Gallucci M; Sotgiu A
    Stud Health Technol Inform; 2003; 95():164-9. PubMed ID: 14663981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI features of pediatric multiple sclerosis.
    Banwell B; Shroff M; Ness JM; Jeffery D; Schwid S; Weinstock-Guttman B;
    Neurology; 2007 Apr; 68(16 Suppl 2):S46-53. PubMed ID: 17438238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
    Bö L; Geurts JJ; van der Valk P; Polman C; Barkhof F
    Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis.
    Sombekke MH; Wattjes MP; Balk LJ; Nielsen JM; Vrenken H; Uitdehaag BM; Polman CH; Barkhof F
    Neurology; 2013 Jan; 80(1):69-75. PubMed ID: 23243070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
    Villar LM; Espiño M; Roldán E; Marín N; Costa-Frossard L; Muriel A; Alvarez-Cermeño JC
    Mult Scler; 2011 Jun; 17(6):690-4. PubMed ID: 21436320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance imaging in multiple sclerosis].
    Oda M; Udaka F
    Nihon Rinsho; 2008 Jun; 66(6):1098-102. PubMed ID: 18540354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting state networks change in clinically isolated syndrome.
    Roosendaal SD; Schoonheim MM; Hulst HE; Sanz-Arigita EJ; Smith SM; Geurts JJ; Barkhof F
    Brain; 2010 Jun; 133(Pt 6):1612-21. PubMed ID: 20356855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI in multiple sclerosis: a review of the current literature.
    Ceccarelli A; Bakshi R; Neema M
    Curr Opin Neurol; 2012 Aug; 25(4):402-9. PubMed ID: 22691759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.